Physician profile
Joshua Bederson
NPI 1821064569
$11,962.43
in general payments reported to CMS, 2019-2025
8 companies · $91.57 in 2025
The $91.57 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7,753 · 2021: $2,145 · 2022: $1,821 · 2023: $152 · 2025: $91.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Theater. INC. | $7,767.14 | 2020-2023 | |
| Carl Zeiss Meditec Ag | $2,000.00 | 2021 | |
| Leica Microsystems (Schweiz) Ag | $1,594.24 | 2022 | |
| Stryker Corporation | $265.79 | 2020-2021 | |
| Leica Microsystems Cms Gmbh | $226.40 | 2022 | |
| Integra Lifesciences Corporation | $91.57 | 2025 | Codman Hakim, Duraseal Exact Spinal Sealant System, Codman Certas |
| Medtronic USA, INC. | $17.29 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,421,293.63 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bederson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.